Publication | Closed Access
FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer
185
Citations
24
References
2013
Year
Gastrointestinal OncologyMedicinePharmacologyPathologyColorectal CancerFirst-line TreatmentCancer TreatmentOncologyRadiation OncologyMolecular Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1